Rejected at 5:51 p.m. Mar, 09, 2024 ] by Cameron
Author: ryanantar
Co-authors: Cameron
Related Note: 1472502704876
Rationale for change

including reasoning:

- this is due to inhibition of colonic migrating motor complex (MMC)
- this is not seen in dihydropyridine Ca2+ channel blockers
Source: UWorld - Step 1 17003

Rejection reason

Would need clarity on importance for answering the listed QID with this new information

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#UWorld::Step::17003 #AK_Other::Only_Step_1 #PANCE::EOR::IM #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::01_Hypertension_Treatment #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::03_Antihypertensives::01_Calcium_channel_blockers #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#UWorld::Step::153 #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::03_Calcium_channel_blockers #PANCE::EOR::Family_med #PANCE::CARDIO::hypertension #AK_Step1_v12::^Systems::Cardio::Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::20_Class_IV_Antiarrhythmics #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::09_Class_IV_Antiarrhythmics #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::14_Class_IV_Antiarrhythmics-Verapamil #AK_Step1_v12::#B&B::06_Cardio::08_Hypertension::03_Antihypertensives_I #PANCE::GI::colorectal_disorders #AK_Step2_v12::!Shelf::IM #AK_Step1_v12::#Bootcamp::Cardiology::07_Vasodilation_and_Vasoconstriction::04_Pharmacologic_Targets #AK_Step2_v12::#B&B::02_Cardio::05_Pharm::01_Cardiovascular_Pharmacology_I #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#UWorld::COMLEX::26604 #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::05_Antiarrhythmic_Drugs #AK_Step1_v12::#UWorld::COMLEX::23266 #AK_Step1_v12::#OME::PreClinical::Cardiac #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::08_Antianginal_Drugs #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::07_Calcium_Channel_Blockers_(MOA,_Indications,_AR,_CI) #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::02_Calcium_Channel_Blockers